Over the past 12 months, 0 insiders at Regulus Therapeutics Inc. filed 0 open-market SEC Form 4 transactions on RGLS: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 3, 25 | Preston KlassenPresident & Head of R & D | BUY | 12.0K | $7.99 | $96K |
| Jan 30, 25 | David BaltimoreDirector | BUY | 19.6K | $1.06 | $21K |
| Jan 30, 25 | Joseph P HaganChief Executive Officer | BUY | 50.0K | $1.09 | $55K |
| Jan 14, 25 | Christopher Ray AkerSr. VP & General Counsel | SELL | 5.1K | $1.26 | $6K |
| Jan 14, 25 | Crispina CalsadaChief Financial Officer | SELL | 5.1K | $1.26 | $6K |
| Jan 14, 25 | Joseph P HaganChief Executive Officer | SELL | 11.8K | $1.26 | $15K |
| Jan 13, 25 | Christopher Ray AkerSr. VP & General Counsel | SELL | 38.5K | $1.26 | $49K |
| Jan 13, 25 | Crispina CalsadaChief Financial Officer | SELL | 38.7K | $1.26 | $49K |
| Jan 13, 25 | Joseph P HaganChief Executive Officer | SELL | 115.3K | $1.26 | $145K |
| Jan 13, 25 | Preston KlassenPresident & Head of R & D | SELL | 31.4K | $1.26 | $40K |
| Jul 25, 24 | Kathryn J CollierDirector | BUY | 4.0K | $1.82 | $7K |
| Jan 18, 24 | Christopher Ray AkerSr. VP & General Counsel | SELL | 5.5K | $1.19 | $7K |
| Jan 18, 24 | Crispina CalsadaChief Financial Officer | SELL | 5.5K | $1.19 | $7K |
| Jan 18, 24 | Joseph P HaganChief Executive Officer | SELL | 14.6K | $1.19 | $17K |
| Mar 1, 22 | Denis DryginChief Scientific Officer | BUY | 76.7K | $0.23 | $18K |
| Feb 4, 22 | Denis DryginChief Scientific Officer | BUY | 23.3K | $0.23 | $5K |
| Jan 26, 22 | Joseph P HaganPresident and CEO | BUY | 100.0K | $0.22 | $22K |
Over the past 12 months, insiders at Regulus Therapeutics Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on RGLS, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market RGLS insider purchase in our data was $96K by Preston Klassen, President & Head of R & D, filed on Jun 3, 25.
0 different insiders at Regulus Therapeutics Inc. filed open-market SEC Form 4 transactions on RGLS over the last 12 months.
InsiderTape plots every RGLS insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Regulus Therapeutics Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →